Home
About
FAQ
History (2)
Alzheimer disease blood biomarkers: considerations for population-level use.
Relation of the CHA2DS2-VASc Score to Risk of Thrombotic and Embolic Stroke in Community-Dwelling Individuals Without Atrial Fibrillation (From The Atherosclerosis Risk in Communities [ARIC] Study).
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Alzheimer disease blood biomarkers: considerations for population-level use.
Mielke MM, Fowler NR. Alzheimer disease blood biomarkers: considerations for population-level use. Nat Rev Neurol. 2024 Aug; 20(8):495-504.
View in:
PubMed
subject areas
Alzheimer Disease
Humans
authors with profiles
Michelle M. Mielke PhD